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Phase III Elimination: Another
Two-Edged Sword
Excretion into bile is well recognized as a major pathway for the
elimination of amphipathic, hydrophobic, high molecular weight
xenobiotics and thus complements the renal elimination of
hydrophilic compounds oflow molecular weight. For many xeno-
biotics, excretion in bile, which has been termed a phase III elimina-
tion reaction (1), begins with an oxidation reaction (phase I), followed
by conjugation (phase II), usually to glucuronide or glutathione.
conjugates, which are good substrates
for biliary excretory pathways. Until
recently, there was little understanding Iu9on ol
regarding the mechanisms by which
substrates are concentrated in bile or
regarding what determines the sub-
strate specificity of the transporters.
The identification of distinct ATP-
dependent and voltage-dependent
transporters in the canalicular mem-
brane over the last few years has begun
to provide answers to these questions.
Important questions that have not been
addressed, and which are critical for
toxicology, relate to the regulation of Excretion in b
the activities of these transporters by
endogenous, or more importantly, envi- Phase Ill elimination reactions i
ronmental agents. Two examples illus- liver(phase I),followed byconij
trate the importance of concentrative
transport into bile for toxicity and how
regulation ofthis process and the subsequent fate ofthese conjugates
might influence toxicity.
Technical-grade dinitrotoluene (DNT) consists primarily of
2,4-DNT (75.8%) and 2,6-DNT (19.5%) and is hepatocarcinogenic
when fed to Fischer-344 rats. After administration of 35 mg
DNT/kg/day for 55 weeks, the incidence ofhepatocellular carcinomas
in female rats was halfthat in males (2). In an elegant series ofstudies,
Rickert and colleagues suggested a bioactivation pathway involving
hepatic metabolism to dinitrobenzyl glucuronide followed by biliary
excretion, deconjugation, and nitroreduction by intestinal microflora,
and finally reabsorption ofthe resulting aminonitrobenzyl alcohol,
whichwas then oxidized to reactive metabolites whichwere genotoxic.
A key rate-determining step in the development ofhepatocarcinoma
was the rate and extent to which the glucuronide conjugate was
delivered to the microflora in the gastrointestinal tract, which was
several-fold lower in female rats.
Why is biliary excretion of this substrate lower in female rats?
Based on the decreased biliary excretion ofmany substrates during
pregnancy, and following treatment with estradiol, ethinyl estradi-
ol, or diethylstilbestrol, it seems most likely that estrogens are impor-
tant regulators of phase III elimination. The mechanism by which
estrogens inhibit this process is not known, but the selective changes
induced by treatment of rats with ethinyl estradiol (i.e., inhibition
of some transporters; ATP-dependent transport of bile acids) but
stimulation of others (Na+/glycine cotransport) in rat canalicular
membrane vesicles suggest estrogen-receptor-mediated events,
rather than a generalized "toxic" response (3,4).
Are environmental estrogens (e.g., chlordecone, DDT) able to
interact with hepatic estrogen receptors and simulate the inhibitory
effects ofclassic estrogens on biliary excretion? Interestingly, the bil-
iary excretion ofseveral substrates is increased postpartum in lactat-
ing rats; this effect has recently been shown to be mediated by the
anterior pituitary hormone prolactin (5). Estrogens increase gene
transcription and secretion ofprolactin. Do environmental estrogens
also stimulate prolactin release and thus blunt the inhibitory effects
of estrogens on biliary excretion? The inhibitory effect ofestrogens
on the phase III elimination pathway
' in the rat parallels the decreased bile
xonobiotic 2" secretary function seen in normal
- women in the third trimester of preg-
nancy and during treatment with
estrogen-containing oral contracep-
tives. However, the female rat liver has
an exceptionally high number of pro-
lactin receptors so that the rat may not
be a good predictor of the human
hepatic response to increased prolactin
secretion.
A second example illustrates the
toxicological importance of hydrolysis
lie(phaseIII) of glutathione conjugates following
their excretion into bile. The nephro-
n bile begin with oxidation in the toxicity of cysteine-S conjugates is
gation(phase 11). well-known (6), and has been shown
to require formation of an S-glu-
tathione conjugate in the liver, fol-
lowed by secretion into bile. The ectoenzymes, gamma-glutamyl-
transferase (GGT) and dipeptidases are then able to catalyze its
hydrolysis to cysteine-S conjugates. The high concentrations of
GGT in the intestine and kidney relative to the liver led initially to
the concept that these organs were required for formation of cys-
teine-Sconjugates. Ballatori and colleagues (7) have shown that this
may be true for the rat and mouse, which have very low levels of
hepatic GGT, but is unlikely for species like the guinea pig and
man, which have relatively high concentrations of GGT in the bil-
iary tree. In the guinea pig, glutathione conjugates are readily
hydrolyzed within the biliary tree to the cysteine-Sconjugates which
can then be reabsorbed from the bile back into the liver. This GGT-
dependent biliary-hepatic recycling has been shown to contribute to
the long biologic half-life and toxicity of methyl mercury. Methyl
mercury is thought to be transported into bile across the canalicular
membrane as a glutathione complex which is hydrolyzed by GGT
and dipeptidases to the relatively lipid-soluble methyl mercury-cys-
teine complex (8). Changes in the activity of hepatic GGT could
therefore influence the retention and thus the toxicity of methyl
mercury. What regulates GGT activity, and is this influence by envi-
ronmental factors? Lieberman and colleagues (9) have recently
cloned the 5' region ofthe mouse GGT gene and have shown that a
single gene codes for six different mRNAs with alternative 5'
sequences, suggestive of 5-6 distinct promoters in the upstream
region ofthe gene. Differential tissue expression and developmental
patterns of the six GGT mRNAs indicate a complex regulation of
this important enzyme.
Thus, like phase I and phase II elimination reactions, phase III
elimination has both detoxification and bioactivation roles, so that
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either inhibition or stimulation ofthis pathway can modulate toxicity.
The challenge will be to begin to unravel the role endogenous factors,
such as pregnancy and lactation, and environmental agents play in
regulating phase III elimination and toxicity in humans.
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